Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × rubitecan × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 21 Temozolomide 19 Irinotecan 16 Vincristine 14 Doxorubicin 11 Topotecan 10 Melphalan 10 Etoposide 9 Busulfan 8 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Magnetic Resonance Spectroscopy 6 Filgrastim 6 cabozantinib 5 X-Rays 5 Sirolimus 5 Drug Therapy 5 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 fludarabine phosphate 4 fludarabine 4 Trabectedin 4 Specimen Handling 4 Phantoms, Imaging 4 Gemcitabine 4 regorafenib 3 irinotecan sucrosofate 3 ganitumab 3 abemaciclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00492141 2012-08-02

Aerosol L9-NC and Temozolomide in Ewing's Sarcoma

M.D. Anderson Cancer Center

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡